Evidence map›Paper›PMID 40655203›Full record

ArticleFrontiers in public health2025

Burden analysis of diabetic nephropathy caused by excessive intake of sugar-sweetened beverages in high and low SDI regions.

Xue Wang, Guangyan Cai, Qing Ouyang, Xiangmei Chen

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. [Burden of Diabetic Kidney Disease at Global, Regional, and National Levels From 1990 to 2021].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xue WangState Key Laboratory of Kidney Diseases, Beijing Key Laboratory of Medical Devices and Integrated Traditional Chinese and Western Drug Development for Severe Kidney Diseases, Beijing Key Laboratory of Digital Intelligent TCM for the Prevention and Treatment of Pan-vascular Diseases, Department of Nephrology, First Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Kidney Diseases, Key Disciplines of National Administration of Traditional Chinese Medicine (zyyzdxk-2023310), Beijing, China.
Guangyan CaiState Key Laboratory of Kidney Diseases, Beijing Key Laboratory of Medical Devices and Integrated Traditional Chinese and Western Drug Development for Severe Kidney Diseases, Beijing Key Laboratory of Digital Intelligent TCM for the Prevention and Treatment of Pan-vascular Diseases, Department of Nephrology, First Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Kidney Diseases, Key Disciplines of National Administration of Traditional Chinese Medicine (zyyzdxk-2023310), Beijing, China.
Qing OuyangState Key Laboratory of Kidney Diseases, Beijing Key Laboratory of Medical Devices and Integrated Traditional Chinese and Western Drug Development for Severe Kidney Diseases, Beijing Key Laboratory of Digital Intelligent TCM for the Prevention and Treatment of Pan-vascular Diseases, Department of Nephrology, First Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Kidney Diseases, Key Disciplines of National Administration of Traditional Chinese Medicine (zyyzdxk-2023310), Beijing, China.
Xiangmei ChenState Key Laboratory of Kidney Diseases, Beijing Key Laboratory of Medical Devices and Integrated Traditional Chinese and Western Drug Development for Severe Kidney Diseases, Beijing Key Laboratory of Digital Intelligent TCM for the Prevention and Treatment of Pan-vascular Diseases, Department of Nephrology, First Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Kidney Diseases, Key Disciplines of National Administration of Traditional Chinese Medicine (zyyzdxk-2023310), Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The Global Burden of Disease Study (GBD) 2019 reveals an increasing prevalence of diabetic nephropathy caused by excessive intake of sugar-sweetened beverages in high and low SDI regions from 1990 to 2021. Methods: This study comprehensively analyzed the burden of DN caused by SSBs in high and low SDI regions from 1990 to 2021 and projected the trends until 2040 using ARIMA models. Results: The results revealed distinct patterns and trends in age-standardized rates of deaths, DALYs, YLDs, and YLLs between the two regions. In high SDI regions, the age-standardized rates of deaths, DALYs, YLDs, and YLLs exhibited a consistent upward trend from 1990 (0.044, 1.425, 0.537, 0.888 per 100,000) to 2021 (0.096, 2.284, 0.67, 2.154 per 100,000). Projections for the age-standardized rates in high SDI regions from 2021 to 2040 indicate that these upward trends will persist, with deaths, DALYs, YLDs, and YLLs further increasing to 0.127, 3.629, 1.070, and 2.861 per 100,000. Conversely, low SDI regions displayed different trends. Although the age-standardized rates of deaths, DALYs, YLDs, and YLLs also increased from 1990 (0.018, 0.488, 0.071, 0.417 per 100,000) to 2021 (0.020, 0.522, 0.081, 0.441 per 100,000), the rate of increase was relatively slower compared to high SDI regions. Projections for the age-standardized rates in low SDI regions from 2021 to 2040 suggest that these upward trends will continue, with deaths, DALYs, YLDs, and YLLs further increasing to 0.016, 0.498, 0.105, and 0.398 per 100,000. Conclusion: This study provides a comprehensive analysis of the burden of type 2 diabetes nephropathy caused by excessive intake of sugar-sweetened beverages in high and low SDI regions. The results revealed distinct patterns and trends in age-standardized rates of deaths, DALYs, YLDs, and YLLs between the two regions.

Indexed as

Diabetic NephropathiesSugar-Sweetened BeveragesAdultFemaleGlobal Burden of DiseaseHumansMaleMiddle AgedPrevalenceARIMADALYsdeathsdiabetic nephropathyexcessive intake of sugar-sweetened beveragessocio-demographic indexYLDsYLLs

Identifiers

PMID40655203
PMCPMC12248067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.